For: | Shan GY, Wan H, Zhang YX, Cheng JY, Qiao DR, Liu YY, Shi WN, Li HJ. Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Hepatol 2024; 16(10): 1142-1150 [PMID: 39474575 DOI: 10.4254/wjh.v16.i10.1142] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v16/i10/1142.htm |
Number | Citing Articles |
1 |
Muhammad Asim, Aleena Altaf, Aamir Sohail, Maimoona Arshad, Faiza Noreen, Idrees Raza, Hamza Muneer, Muhammad Murtaza Hasnain, Raza Sufyan, Imran Ullah. Steatosis - Causes and Treatment [Working Title]. 2025; doi: 10.5772/intechopen.1011551
|
2 |
Xinyang Huang, Zihao Deng, Xiaozhou Li, Songxin Yan, Kunjiang Zhong, Fengning Yuan, Ligang Liu, Chaolin Deng, Tingting Liu, Ruizhao Zhao, Amin Buhe, Tianxiong Li, Hao Zhao. Serum LEAP2 Levels Across the Spectrum of Metabolic Dysfunction-Associated Fatty Liver Disease: A Potential Noninvasive Biomarker for Severity Stratification. Diabetes, Metabolic Syndrome and Obesity 2025; : 2439 doi: 10.2147/DMSO.S536270
|
3 |
D. V. Emelyanov. Особливості стоматологічного статусу хворих при різних патогенетичних формах неалкогольної жирової хвороби печінки. Likarska sprava 2025; (1) doi: 10.31640/LS-2025-1-04
|
4 |
Abdallah Hussein, Ameer Awashra, Islam Rajab, Mohammad Bdair, Dawoud Hamdan, Ahmad Nouri, Elaf Khatib, Ghiras Khatib, Nyan Latt. Comparative Effectiveness of Bariatric Surgery Versus GLP‐1 Receptor Agonists in Reducing the Risk of New‐Onset of NASH: A Retrospective Multinational Cohort Study From North America and Europe. Endocrinology, Diabetes & Metabolism 2025; 8(4) doi: 10.1002/edm2.70075
|